Skip to main content Accessibility help

Predictors of Hospital-Acquired Urinary Tract–Related Bloodstream Infection

  • M. Todd Greene (a1) (a2), Robert Chang (a1) (a2), Latoya Kuhn (a2) (a3), Mary A. M. Rogers (a1) (a2), Carol E. Chenoweth (a4) (a5), Emily Shuman (a4) and Sanjay Saint (a1) (a2) (a3)...



Bloodstream infection (BSI) secondary to nosocomial urinary tract infection is associated with substantial morbidity, mortality, and additional financial costs. Our objective was to identify predictors of nosocomial urinary tract-related BSI.


Matched case-control study.


Midwestern tertiary care hospital.


Cases n = 298) were patients with a positive urine culture obtained more than 48 hours after admission and a blood culture obtained within 14 days of the urine culture that grew the same organism. Controls (n = 667), selected by incidence density sampling, included patients with a positive urine culture who were at risk for BSI but did not develop one.


Conditional logistic regression and classification and regression tree analyses.


The most frequently isolated microorganisms that spread from the urinary tract to the bloodstream were Enterococcus species. Independent risk factors included neutropenia (odds ratio [OR], 10.99; 95% confidence interval [CI], 5.78-20.88), renal disease (OR, 2.96; 95% CI, 1.98-4.41), and male sex (OR, 2.18; 95% CI, 1.52-3.12). The probability of developing a urinary tract-related BSI among neutropenic patients was 70%. Receipt of immunosuppressants (OR, 1.53; 95% CI, 1.04-2.25), insulin (OR, 4.82; 95% CI, 2.52-9.21), and antibacterials (OR, 0.66; 95% CI, 0.44-0.97) also significantly altered risk.


The heightened risk of urinary tract-related BSI associated with several comorbid conditions suggests that the management of nosocomial bacteriuria may benefit from tailoring to certain patient subgroups. Consideration of time-dependent risk factors, such as medications, may also help guide clinical decisions in reducing BSI.

Infect Control Hosp Epidemiol 2012;33(10):1001-1007


Corresponding author

University of Michigan Health System, 2800 Plymouth Road, Building 16-Room 470C, Ann Arbor, MI 48109 (


Hide All
1.Klevens, RM, Edwards, JR, Andrus, ML, Peterson, KD, Dudeck, MA, Horan, TC. Dialysis surveillance report: National Healthcare Safety Network (NHSN)—data summary for 2006. Semin Dial 2008;21(1):2428.
2.Saint, S, Kaufman, SR, Rogers, MA, Baker, PD, Boyko, EJ, Lipsky, BA. Risk factors for nosocomial urinary tract-related bacteremia: a case-control study. Am J Infect Control 2006;34(7):401407.
3.Chang, R, Greene, MT, Chenoweth, CE, et al.Epidemiology of hospital-acquired urinary tract-related bloodstream infection at a university hospital. Infect Control Hosp Epidemiol 2011;32(11): 11271129.
4.Saint, S, Meddings, JA, Calfee, D, Kowalski, CP, Krein, SL. Catheter-associated urinary tract infection and the Medicare rule changes. Ann Intern Med 2009;150(12):877884.
5.Jerkeman, M, Braconier, JH. Bacteremic and non-bacteremic febrile urinary tract infection—a review of 168 hospital-treated patients. Infection 1992;20(3):143145.
6.Krieger, JN, Kaiser, DL, Wenzel, RP. Urinary tract etiology of bloodstream infections in hospitalized patients. J Infect Dis 1983; 148(1):5762.
7.Bahagon, Y, Raveh, D, Schlesinger, Y, Rudensky, B, Yinnon, AM. Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis 2007;26(5):349352.
8.Leibovici, L, Greenshtain, S, Cohen, O, Wysenbeek, AJ. Toward improved empiric management of moderate to severe urinary tract infections. Arch Intern Med 1992;152(12):24812486.
9.Rothman, KJ, Greenland, S, Lash, TL. Modern Epidemiology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Willems, 2008.
10.Breiman, L. Classification and Regression Trees. Belmont, CA: Wadsworth International Group, 1984.
11.Vanhorebeek, I, Langouche, L, Van den Berghe, G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 2007;132(1):268278.
12.Grey, NJ, Perdrizet, GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemie control. Endocr Pract 2004; 10(suppl 2):4652.
13.Griebling, TL. Urinary tract infection in women. In: Litwin, MS, Saigai, CS, eds. Urologie Diseases in America. Washington, DC: National Institute of Diabetes and Digestive and Kidney Diseases, 2007.
14.Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta: Centers for Disease Control and Prevention, US Department of Health and Human Services, 2011.
15.Joshi, N, Caputo, GM, Weitekamp, MR, Karchmer, AW. Infections in patients with diabetes mellitus. N Engl J Med 1999;341(25): 19061912.
16.Jeon, C. Increase in glucose levels in inpatients may indicate bloodstream infections. Paper presented at: 51st International Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 2011; Chicago.
17.Urabe, A. Clinical features of the neutropenic host: definitions and initial evaluation. Clin Infect Dis 2004;39(suppl 1):S53S55.
18.Feld, R. Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents 2008;32(suppl 1):S30S33.
19.Edmond, MB, Wallace, SE, McClish, DK, Pfaller, MA, Jones, RN, Wenzel, RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999;29(2): 239244.
20.Nassar, GM, Ayus, JC. Infectious complications of the hemodialysis access. Kidney Int 2001;60(1):113.
21.James, MT, Laupland, KB, Tonelli, M, Manns, BJ, Culleton, BF, Hemmelgarn, BR. Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis. Arch Intern Med 2008;168(21):23332339.
22.Dalrymple, LS, Go, AS. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol 2008;3(5):14871493.
23.Foley, RN. Infections in patients with chronic kidney disease. Infect Dis Clin North Am 2007;21(3):659672, viii.
24.Bittencourt, PL, de Carvalho, GC, de Andrade Regis, C, et al.Causes of renal failure in patients with decompensated cirrhosis and its impact in hospital mortality. Ann Hepatol 2012;11(1): 9095.
25.Almog, Y. Statins, inflammation, and sepsis: hypothesis. Chest 2003;124(2):740743.
26.McGown, CC, Brookes, ZL. Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. Br J Anaesth 2007;98(2):163175.
27.Mekontso-Dessap, A, Brun-Buisson, C. Statins: the next step in adjuvant therapy for sepsis? Intensive Care Med 2006;32(1): 1114.
28.Merx, MW, Liehn, EA, Janssens, U, et al.HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation 2004;109(21):25602565.
29.Terblanche, M, Almog, Y, Rosenson, RS, Smith, TS, Hackam, DG. Statins: panacea for sepsis? Lancet Infect Dis 2006;6(4):242248.

Related content

Powered by UNSILO

Predictors of Hospital-Acquired Urinary Tract–Related Bloodstream Infection

  • M. Todd Greene (a1) (a2), Robert Chang (a1) (a2), Latoya Kuhn (a2) (a3), Mary A. M. Rogers (a1) (a2), Carol E. Chenoweth (a4) (a5), Emily Shuman (a4) and Sanjay Saint (a1) (a2) (a3)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.